EUVIMEDEUVIMED entdecken
Open Access

Drug-Induced Hyponatremia Surveillance: A disproportionality analysis based on FAERs database

Xin Xi, Zhanfeng Bai, Songqing Liu, Jie Dong

Pakistan Journal of Medical Sciences · 11.04.2026 · 42 (4) · 848-855

DOI: 10.12669/pjms.42.4.13918 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pakistan Journal of Medical Sciences, online erschienen am 11.04.2026. Verfasst von Xin Xi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Xin Xi Pharmacy Department, The Third Affiliated Hospital of, Chongqing Medical University, Chongqing, China. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Mining the risk signals of drug-induced hyponatremia by the United States Food and Drug Administration adverse event reporting system (FAERS) database, to provide reference for clinical safe medication. Methodology: Adverse drug events related to drug induced hyponatremia were analyzed by disproportionality analysis using the FAERS data between 2004 to 2023 were downloaded (https://fis.fda.gov/extensions/FPD-QDE-FAERS/FPD-QDE-FAERS.html).

Results

A total of 1,306 drugs with identifiable risk signals were associated with Hyponatremia. Five drugs demonstrated the highest cases counts: furosemide (n=1,560), hydrochlorothiazide (n=1049), sertraline (n=899), omeprazole(n=864), citalopram (n=738). The pharmacovigilance analysis identified five substances exhibiting the strongest association signals: indapamide (ROR=91.46, 95% CI 83.38-100.32), hydrochlorothiazide (ROR=46.79, 95% CI 43.96-49.81), desmopressin (ROR=34.08, 95% CI 31.49-36.89), oxcarbazepine (ROR=24.47, 95% CI 22.72-26.37), and furosemide (ROR=24.11, 95% CI 22.91-25.37). Nivolumab (36.92%), bortezomib (30.58%), and zoledronic (29.36%) exhibited the highest proportional occurrence of target adverse events involving fatal or life-threatening outcomes. Additionally, clinical information about Drug-induced hyponatremia is absent from the Summary of Product Characteristics of 10 drugs in our study.

Conclusions

We provide a list of drugs with risk signals for Hyponatremia. In clinical practice, it is helpful to identify the culprit drug early, and prevent it from further aggravation into a serious condition.

Schlagwörter

Stichwörter der Autor:innen

FAERS databaseHyponatremiaReporting odds ratio

Autor:innen und Institutionen

  • Xin Xi Pharmacy Department, The Third Affiliated Hospital of, Chongqing Medical University, Chongqing, China.
  • Zhanfeng Bai Pharmacy Department, The Third Affiliated Hospital of, Chongqing Medical University, Chongqing, China.
  • Songqing Liu Pharmacy Department, The Third Affiliated Hospital of, Chongqing Medical University, Chongqing, China.
  • Jie Dong Pharmacy Department, The Third Affiliated Hospital of, Chongqing Medical University, Chongqing, China.

Zitieren

APA

Xi, X., Bai, Z., Liu, S., & Dong, J. (2026). Drug-Induced Hyponatremia Surveillance: A disproportionality analysis based on FAERs database. Pakistan Journal of Medical Sciences, 42(4), 848-855. https://doi.org/10.12669/pjms.42.4.13918

Vancouver

Xi X, Bai Z, Liu S, Dong J. Drug-Induced Hyponatremia Surveillance: A disproportionality analysis based on FAERs database. Pakistan Journal of Medical Sciences. 2026;42(4):848-855. doi:10.12669/pjms.42.4.13918

BibTeX
@article{Xi2026,
  author = {Xi, Xin and Bai, Zhanfeng and Liu, Songqing and Dong, Jie},
  title = {Drug-Induced Hyponatremia Surveillance: A disproportionality analysis based on FAERs database},
  journal = {Pakistan Journal of Medical Sciences},
  year = {2026},
  volume = {42},
  number = {4},
  pages = {848--855},
  doi = {10.12669/pjms.42.4.13918}
}
Kostenlos starten →